ArticleMolecular pharmacology2013

Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia.

David L Hermanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.